Prelude Capital Management’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,428
Closed -$672K 2443
2018
Q3
$672K Buy
10,428
+8,545
+454% +$521K 0.04% 453
2018
Q2
$92K Buy
+1,883
New +$97.5K 0.01% 956
2017
Q2
Sell
-1,342
Closed -$88K 2086
2017
Q1
$88K Sell
1,342
-465
-26% -$28.7K 0.01% 828
2016
Q4
$103K Sell
1,807
-575
-24% -$33.3K 0.01% 817
2016
Q3
$141K Buy
2,382
+468
+24% +$28.1K 0.01% 692
2016
Q2
$125K Buy
+1,914
New +$130K 0.02% 674
2016
Q1
Sell
-110
Closed -$8K 1807
2015
Q4
$8K Buy
+110
New +$7.82K ﹤0.01% 1285
2015
Q1
Sell
-1,103
Closed -$79K 2453
2014
Q4
$79K Sell
1,103
-87
-7% -$6.03K 0.01% 1096
2014
Q3
$82K Buy
+1,190
New +$83.7K 0.01% 1180
2014
Q2
Sell
-380
Closed -$21K 2476
2014
Q1
$21K Sell
380
-20
-5% -$1.07K ﹤0.01% 1681
2013
Q4
$21K Buy
400
+300
+300% +$15.1K ﹤0.01% 1332
2013
Q3
$5K Buy
+100
New +$4.79K ﹤0.01% 1506

Other funds holding LPNT

Prelude Capital Management's LPNT Position: Q4 2018 in Review

Prelude Capital Management sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 10,428 shares — an estimated $672K sold.

Prelude Capital Management first reported a position in LPNT in Q3 2013 and held it in 12 quarters. The position peaked at $672K in Q3 2018. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

  • Prelude Capital Management reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Prelude Capital Management sold 10,428 LifePoint Health, Inc. shares in Q4 2018, an estimated $672K.
  • Prelude Capital Management first reported a position in LifePoint Health, Inc. in Q3 2013 and held it in 12 quarters.
  • Prelude Capital Management's LifePoint Health, Inc. position peaked at $672K in Q3 2018.
  • 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.